Agilent Technologies vs BeOne Medicines
Agilent Technologies (A), health care, and BeOne Medicines (ONC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Agilent Technologies is worth $48.6B on the stock market and BeOne Medicines $47.2B: Agilent Technologies is valued at 3% more. Agilent Technologies trades at 34.0 times earnings and BeOne Medicines at 53.0; operating margins in their latest fiscal years were 21.3% and 8.37%. Over the past year Agilent Technologies's share price has moved +20.2% and BeOne Medicines's +13.0%.
Key facts
- Agilent Technologies market value
- $48.6B
- BeOne Medicines market value
- $47.2B
- Agilent Technologies P/E
- 34.0
- BeOne Medicines P/E
- 53.0
- Agilent Technologies revenue
- $6.9BFY to 2025-10-31
- BeOne Medicines revenue
- $5.3BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Agilent Technologies | BeOne Medicines |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-10-31 | 2025-12-31 |
| Size | ||
| Market cap | $48.6Bhigher | $47.2Blower |
| Revenue | $6.9Bhigher | $5.3Blower |
| Earnings | $1.3Bhigher | $286.9Mlower |
| Employees | 18,200higher | 12,000lower |
| Total assets | $12.7Bhigher | $8.2Blower |
| Valuation | ||
| P/E | 34.0lower | 53.0higher |
| P/S | 7.0lower | 8.8higher |
| P/B | 6.6 | — |
| Dividend yield | 0.59% | — |
| Profitability | ||
| Operating margin | 21.3%higher | 8.37%lower |
| Balance sheet | ||
| Net assets | $6.7Bhigher | $4.4Blower |
| Total liabilities | $6Bhigher | $3.8Blower |
| Total debt | $3.4Bhigher | $1Blower |
| Cash on hand | $1.8Blower | $4.5Bhigher |
| Price change | ||
| Today | -0.42%lower | +0.48%higher |
| 1 year | +20.2%higher | +13.0%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Primecap team0.1% / 1.1%
Agilent Technologies only (3)
- Larry Robbins5.2%
- Cliff Asness0.2%
- Edgar Wachenheim<0.1%
BeOne Medicines only (5)
Percentages are each holding's share of that investor's reported portfolio (under "Both": Agilent Technologies / BeOne Medicines). Who owns A · Who owns ONC
More on Agilent Technologies
Further comparisons
Agilent Technologies against its closest peers
BeOne Medicines against its closest peers
Learn
Questions and answers
Which is bigger, Agilent Technologies or BeOne Medicines?
By market value, Agilent Technologies is the larger: $48.6B against $47.2B for BeOne Medicines. By revenue in its latest fiscal year, Agilent Technologies is the larger: $6.9B against $5.3B for BeOne Medicines.
Which has the higher P/E ratio?
BeOne Medicines: 53.0, against 34.0 for Agilent Technologies. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Agilent Technologies: 21.3%, against 8.37% for BeOne Medicines. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Agilent Technologies: $3.4B, against $1B for BeOne Medicines. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Agilent Technologies and BeOne Medicines?
In their latest 13F filings, Primecap team holds both.
Cite this page
Funkfolio, “Agilent Technologies vs BeOne Medicines”, data as of 17 November 2026. https://funkfolio.com/compare/a-vs-onc
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.